Blake S Moses

Title: Innovations in Cancer Treatment by Blake S. Moses

Introduction

Blake S. Moses is an accomplished inventor based in Timonium, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving therapeutic methods has the potential to impact many lives.

Latest Patents

Blake S. Moses holds a patent for "Combinations of artemisinins, BCL-2 inhibitors, and kinase inhibitors for cancer treatment." This patent details methods of treating cancer, such as leukemia, by administering therapeutically effective amounts of artemisinins alongside additional therapeutic agents. The artemisinins mentioned in his patent include artesunate, dihydroartemisinin, artemether, arteether, artelinate, ART-631, and ART-838. The additional therapeutic agents comprise BCL-2 inhibitors like ABT-199, ABT-263, and ABT-737, as well as kinase inhibitors such as lestaurtinib, midostaurin, and sorafenib. Furthermore, anti-neoplastic agents like cytarabine, doxorubicin, etoposide, cyclophosphamide, triplotide, vinorelbine, cisplatin, and rituximab are also included in his innovative approach.

Career Highlights

Blake S. Moses is affiliated with the University System of Maryland, where he continues to advance his research in cancer treatment. His work is characterized by a commitment to developing effective therapies that can significantly improve patient outcomes.

Collaborations

One of his notable collaborators is Curt I. Civin, with whom he has worked closely to further their research initiatives.

Conclusion

Blake S. Moses is a pioneering inventor whose work in cancer treatment exemplifies the intersection of innovation and healthcare. His contributions through patents and research are paving the way for new therapeutic options in the fight against cancer.